{"id":"W1995904050","doi":"10.1086/605431","title":"Use of Peroxisome Proliferator‐Activated Receptor γ Agonists as Adjunctive Treatment for <i>Plasmodium falciparum</i> Malaria: A Randomized, Double‐Blind, Placebo‐Controlled Trial","year":2009,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Malaria Research and Control","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"North York General Hospital; University of Toronto; University Health Network; Toronto General Hospital","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Genome Canada; Ontario Genomics; Ontario Genomics Institute; University of Washington; GlaxoSmithKline","keywords":"Malaria; Medicine; Rosiglitazone; Adjunctive treatment; Plasmodium falciparum; Case fatality rate; Placebo; Immunology; Artemisinin; Peroxisome proliferator-activated receptor; Pharmacology; Internal medicine; Receptor; Epidemiology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00114124,0.0005822028,0.003748931,0.0002790226,0.0002236302,0.0001427475,0.0001600786,0.0004691729,0.000325667],"category_scores_gemma":[0.01043518,0.0003977079,0.002617848,0.0003152207,0.000449283,0.0002788384,0.00004043531,0.0004286864,0.00005385844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002511625,"about_ca_system_score_gemma":0.001522573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009029127,"about_ca_topic_score_gemma":0.00001797336,"domain_scores_codex":[0.9949073,0.0009425301,0.001912,0.0008767962,0.0005961706,0.0007651998],"domain_scores_gemma":[0.9910349,0.005605808,0.0007028135,0.0006909348,0.0008770625,0.001088487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9763789,0.01196757,0.001143771,0.00005865869,0.003581962,0.00003048644,0.00003541417,0.00002424441,0.0005409942,0.002533241,0.001504154,0.002200574],"study_design_scores_gemma":[0.9671507,0.02460453,0.0006706621,0.0001004568,0.003217768,0.000007926897,0.00001664276,0.0005313465,0.001068176,0.0008584484,0.001432663,0.0003406232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9540781,0.0005110155,0.0002628246,0.004455241,0.00101085,0.03812614,0.0002605429,0.0002975738,0.0009976476],"genre_scores_gemma":[0.9870023,0.0004572676,0.00007129553,0.001055611,0.001415296,0.007702823,0.0003057017,0.00005664477,0.001933098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0329241,"threshold_uncertainty_score":0.9998475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06846260567833032,"score_gpt":0.3812203698655188,"score_spread":0.3127577641871885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}